Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction

Código QR

Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction

Background Echocardiography is considered the cornerstone of the diagnostic workup of heart failure with preserved ejection fraction. Thus far, validation of the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging (ASE/EACVI) echo‐algorithm for evaluation of dias...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Arno A. van de Bovenkamp, Vidya Enait, Frances S. de Man, Frank T. P. Oosterveer, Harm Jan Bogaard, Anton Vonk Noordegraaf, Albert C. van Rossum, M. Louis Handoko
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	diagnostics echocardiography heart failure with preserved ejection fraction right heart catheterization Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/8421bb3e5c3b40fa8c6f2af56e8c5a51
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A study of association between heart failure with preserved ejection fraction with hypertension and diabetes mellitus
por: Swapan Sarkar, et al.
Publicado: (2021)

Analgesia, sedación y anestesia para cateterismo diagnóstico y/o terapéutico en pacientes pediátricos con cardiopatías congénitas en el Hospital Clínico de la Pontificia Universidad Católica de Chile: algunas recomendaciones
por: Borchert,Evelyn, et al.
Publicado: (2015)

A Universal New Definition of Heart Failure With Improved Ejection Fraction for Patients With Coronary Artery Disease
por: Haozhang Huang, et al.
Publicado: (2021)

Faltering Under Pressure: Limitations to Noninvasive Diastolic Function Assessments
por: James P. MacNamara, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
por: Marat Fudim, et al.
Publicado: (2021)

Interatrial shunt devices for heart failure with normal ejection fraction: a technology update
por: Cuthbert JJ, et al.
Publicado: (2017)

Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy
por: Amy Hyein Kim, et al.
Publicado: (2022)

Valor pronóstico de la hiperuricemia en la insuficiencia cardíaca crónica
por: Martínez S,Alejandro, et al.
Publicado: (2004)

Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
por: Domingo Pascual-Figal, et al.
Publicado: (2021)

Tricuspid insufficiency after cardiac-implantable electronic device placement
por: Nismat Javed, et al.
Publicado: (2021)

Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction
por: Wan Ting Tay, et al.
Publicado: (2021)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Steffen Pabel, et al.
Publicado: (2021)

Contrast-free percutaneous pulmonary valve replacement: a safe approach for valve-in-valve procedures
por: Barry O’Callaghan, et al.
Publicado: (2021)

Cardiac MRI Based Left Ventricular Global Function Index: Association with Disease Severity in Patients with ICD for Secondary Prevention
por: Andreas Leonhard Schober, et al.
Publicado: (2021)

Clinical course and outcomes of chronic heart failure with preserved left ventricular ejection fraction in concomitant overweight and obesity with comorbid atrial fibrillation
por: P. P. Bidzilya, et al.
Publicado: (2021)

The clinical associations with cardiomegaly in patients undergoing evaluation for pulmonary hypertension
por: Benjamin Daines, et al.
Publicado: (2021)

Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction
por: Yiling Zhou, et al.
Publicado: (2021)

Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction
por: Zheng,Huan, et al.
Publicado: (2014)

Clinical Outcomes of Patients with Coronary Artery Diseases and Moderate Left Ventricular Dysfunction: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery
por: Wang S, et al.
Publicado: (2021)

Causes and predictors of hospital readmissions in patients older than 65 years hospitalized for heart failure with preserved left ventricular ejection fraction in western Romania
por: Mavrea AM, et al.
Publicado: (2015)

Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial
por: Carolyn S. P. Lam, et al.
Publicado: (2021)

Recent and Upcoming Drug Therapies for Pediatric Heart Failure
por: Karla L. Loss, et al.
Publicado: (2021)

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
por: Dzhioeva O, et al.
Publicado: (2020)

The Effects of Hypertension Stages on N-Terminal-Pro Brain Natriuretic Peptide (NT-Pro-BNP) Level and Left Ventricular Ejection Fraction
por: Kati Sriwiyati, et al.
Publicado: (2019)

Reduced ejection fraction heart failure – new data from multicenter studies and national registries regarding general and elderly populations: hopes and disappointments
por: Crișan S, et al.
Publicado: (2018)

Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania
por: Gyalai-Korpos I, et al.
Publicado: (2015)

Systolic Blood Pressure and Outcome in Patients Admitted With Acute Heart Failure: An Analysis of Individual Patient Data From 4 Randomized Clinical Trials
por: Johannes Grand, et al.
Publicado: (2021)

Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis
por: Yibo He, et al.
Publicado: (2021)

Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure
por: Li-fang Ye, et al.
Publicado: (2021)

ANESTHETIC CONCERNS IN PAEDS CARDIAC CATHETERIZATION AT ARMED FORCES INSTITUTE OF CARDIOLOGY / NATIONAL INSTITUTE OF HEART DISEASES
por: Dr Amna, et al.
Publicado: (2020)

Sex, racial differences and healthy aging in normative reference ranges on diastolic function in Ethnic Asians: 2016 ASE guideline revisited
por: Sheng-Nan Chang, et al.
Publicado: (2021)

Case Report: An Unusual Cause for Recurrent Hemopericardium in a Patient With Dyspnea
por: Uyên Châu Nguyên, et al.
Publicado: (2021)

The Prognostic Value of Lung Ultrasound in Patients With Newly Diagnosed Heart Failure With Preserved Ejection Fraction in the Ambulatory Setting
por: Blanka Morvai-Illés, et al.
Publicado: (2021)

Incremental Experience in In Vitro Primary Culture of Human Pulmonary Arterial Endothelial Cells Harvested from <i>Swan-Ganz</i> Pulmonary Arterial Catheters
por: Birger Tielemans, et al.
Publicado: (2021)

Comparison of Pharmacological Treatment Effects on Long-Time Outcomes in Heart Failure With Preserved Ejection Fraction: A Network Meta-analysis of Randomized Controlled Trials
por: Yaowang Lin, et al.
Publicado: (2021)

Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
por: M. A. Manukyan, et al.
Publicado: (2021)

Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation
por: Silvia Oghina, et al.
Publicado: (2021)

Left ventricular assistant devices for end-stage heart failure: report of two cases
por: Pedemonte,Oneglio, et al.
Publicado: (2014)

Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
por: Masatake Kobayashi, et al.
Publicado: (2021)

FREQUENCY OF COMPLIANCE TO GUIDELINE RECOMMENDED TREATMENT IN HEART FAILURE PATIENTS WITH LVEF <40%
por: Ammara Avais, et al.
Publicado: (2020)